PD-L1 immunostaining scoring for non-small cell lung cancer based on immunosurveillance parameters.

Silva, Manuel A; Ryall, Karen A; Wilm, Claudia; Caldara, Jenifer; Grote, Hans Juergen; Patterson-Kane, Janet C

Silva, Manuel A; Ryall, Karen A; Wilm, Claudia; Caldara, Jenifer; Grote, Hans Juergen; Patterson-Kane, Janet C.

Afiliação

Silva MA; Department of Clinical Biomarkers and Companion Diagnostics, Merck KGaA, Darmstadt, Hessen, Germany.
Ryall KA; Department of Pathology, Flagship Biosciences, Inc., Westminster, Colorado, United States of America.
Wilm C; Department of Clinical Biomarkers and Companion Diagnostics, Merck KGaA, Darmstadt, Hessen, Germany.
Caldara J; Department of Pathology, Flagship Biosciences, Inc., Westminster, Colorado, United States of America.
Grote HJ; Department of Clinical Biomarkers and Companion Diagnostics, Merck KGaA, Darmstadt, Hessen, Germany.
Patterson-Kane JC; Department of Pathology, Flagship Biosciences, Inc., Westminster, Colorado, United States of America.

PLoS One ; 13(6): e0196464, 2018.

Article em En | MEDLINE | ID: mdl-29874226

Assuntos

Antígeno B7-H1/metabolismo; Biomarcadores Tumorais/metabolismo; Carcinoma Pulmonar de Células não Pequenas/metabolismo; Neoplasias Pulmonares/metabolismo; Proteínas de Neoplasias/metabolismo; Idoso; Carcinoma Pulmonar de Células não Pequenas/patologia; Feminino; Humanos; Imuno-Histoquímica; Neoplasias Pulmonares/patologia; Masculino; Pessoa de Meia-Idade

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Pulmonar de Células não Pequenas / Antígeno B7-H1 / Neoplasias Pulmonares / Proteínas de Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google